AstraZeneca's total assets for Q2 2026 were $116.43B, an increase of 2.12% from the previous quarter. MX:AZN1N total liabilities were $65.80B for the fiscal quarter, a -1.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.